Cite
APA Citation
Leclerc, D., Staats Pires, A. C., Guillemin, G. J., & Gilot, D. (2021). detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies. Current opinion in immunology, 70, 15–26. http://access.bl.uk/ark:/81055/vdc_100139916075.0x000033